JPWO2020244528A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020244528A5
JPWO2020244528A5 JP2021571970A JP2021571970A JPWO2020244528A5 JP WO2020244528 A5 JPWO2020244528 A5 JP WO2020244528A5 JP 2021571970 A JP2021571970 A JP 2021571970A JP 2021571970 A JP2021571970 A JP 2021571970A JP WO2020244528 A5 JPWO2020244528 A5 JP WO2020244528A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
binding fragment
seq
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021571970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535553A5 (https=
JP2022535553A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/094053 external-priority patent/WO2020244528A1/zh
Publication of JP2022535553A publication Critical patent/JP2022535553A/ja
Publication of JP2022535553A5 publication Critical patent/JP2022535553A5/ja
Publication of JPWO2020244528A5 publication Critical patent/JPWO2020244528A5/ja
Pending legal-status Critical Current

Links

JP2021571970A 2019-06-04 2020-06-03 抗ceacam5モノクローナル抗体、その作製方法およびその使用 Pending JP2022535553A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201910481112 2019-06-04
CN201910481112.6 2019-06-04
PCT/CN2020/094053 WO2020244528A1 (zh) 2019-06-04 2020-06-03 一种抗ceacam5的单克隆抗体及其制备方法和用途

Publications (3)

Publication Number Publication Date
JP2022535553A JP2022535553A (ja) 2022-08-09
JP2022535553A5 JP2022535553A5 (https=) 2023-06-12
JPWO2020244528A5 true JPWO2020244528A5 (https=) 2023-06-12

Family

ID=73652171

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021571970A Pending JP2022535553A (ja) 2019-06-04 2020-06-03 抗ceacam5モノクローナル抗体、その作製方法およびその使用
JP2021572365A Active JP7554781B2 (ja) 2019-06-04 2020-06-03 抗ceacam5モノクローナル抗体およびその調製方法およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021572365A Active JP7554781B2 (ja) 2019-06-04 2020-06-03 抗ceacam5モノクローナル抗体およびその調製方法およびその使用

Country Status (10)

Country Link
US (2) US20220235142A1 (https=)
EP (1) EP3981793A4 (https=)
JP (2) JP2022535553A (https=)
KR (1) KR20220016943A (https=)
CN (2) CN113474372B (https=)
AU (1) AU2020289301B2 (https=)
BR (1) BR112021024544A2 (https=)
CA (1) CA3142635A1 (https=)
TW (2) TW202100560A (https=)
WO (2) WO2020244526A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4305069A4 (en) * 2021-03-08 2025-01-01 University of Pittsburgh - of the Commonwealth System of Higher Education MOLECULES THAT BIND TO CD66E POLYPEPTIDES
US12162940B2 (en) 2021-05-05 2024-12-10 Immatics Biotechnologies Gmbh BMA031 antigen binding polypeptides
CN115505043A (zh) * 2021-06-23 2022-12-23 上海吉倍生物技术有限公司 特异性结合糖基化ceacam5的抗体
CN118159564A (zh) * 2021-11-05 2024-06-07 信华生物药业(广州)有限公司 多特异性抗体及其用途
CN116925232A (zh) * 2022-04-02 2023-10-24 普米斯生物技术(珠海)有限公司 靶向ceacam和cd3的多特异性抗体及其用途
KR20250046323A (ko) * 2022-08-10 2025-04-02 머크 샤프 앤드 돔 엘엘씨 Nkg2d, cd16 및 ceacam5에 결합하는 단백질
EP4642810A1 (en) * 2022-12-28 2025-11-05 Full-Life Technologies HK Limited Antibodies specifically binding to ceacam5
CN116376920A (zh) * 2023-03-10 2023-07-04 中山大学附属第五医院 Ceacam5靶向的car-t细胞的制备方法及应用
EP4720134A1 (en) * 2023-06-05 2026-04-08 Nona Biosciences (Suzhou) Co., Ltd. Anti-ceacam5/6 dual-binding antibodies
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof
WO2025257185A1 (en) * 2024-06-11 2025-12-18 Abcely Humanized anti-human-carcinoembryonic antigen antibody
CN118852441B (zh) * 2024-08-30 2025-12-26 四川大学 一种抗ceacam5的纳米抗体及其相关应用
CN119409833A (zh) * 2024-10-25 2025-02-11 华道(上海)生物医药有限公司 一种抗ceacam5和ceacam6双靶向抗体及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
DE69232137T2 (de) 1991-11-25 2002-05-29 Enzon Inc Multivalente antigen-bindende proteine
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
AU701578B2 (en) 1992-08-21 1999-02-04 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
WO1994025591A1 (en) 1993-04-29 1994-11-10 Unilever N.V. PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
WO2005086875A2 (en) * 2004-03-11 2005-09-22 City Of Hope A humanized anti-cea t84.66 antibody and uses thereof
GB0624500D0 (en) * 2006-12-07 2007-01-17 Istituto Superiore Di Sanito A novel passive vaccine for candida infections
EP3009455A1 (en) * 2009-09-16 2016-04-20 Immunomedics Inc. Class i anti-cea antibodies and uses thereof
WO2013054320A1 (en) * 2011-10-11 2013-04-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
HUE033369T2 (en) * 2012-11-20 2017-11-28 Sanofi Sa Anti-ceacam5 antibodies and uses thereof
US20150125386A1 (en) * 2013-11-05 2015-05-07 Immunomedics, Inc. Humanized anti-ceacam5 antibody and uses thereof
CA2874083C (en) * 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
CA2968141C (en) * 2015-01-16 2020-08-04 Hsing-Mao CHU Molecular constructs with targeting and effector elements
PT3274370T (pt) * 2015-03-23 2020-01-30 Bayer Pharma AG Anticorpos anti-ceacam6 e utilizações dos mesmos
CN107708741A (zh) * 2015-06-12 2018-02-16 免疫医疗公司 用嵌合抗原受体(car)构建体和表达car构建体的t细胞(car‑t)或nk细胞(car‑nk)进行的疾病疗法
WO2017172981A2 (en) * 2016-03-29 2017-10-05 University Of Southern California Chimeric antigen receptors targeting cancer
CN108341876B (zh) * 2017-01-22 2021-06-04 中国人民解放军第四军医大学 抗人ceacam5单克隆抗体及其制备方法和应用
TWI795415B (zh) * 2017-07-07 2023-03-11 日商安斯泰來製藥股份有限公司 新穎的抗人類CEACAM5抗體Fab片段

Similar Documents

Publication Publication Date Title
US12583933B2 (en) Anti-CD73 antibody and use thereof
US20230287119A1 (en) Anti-cd3 antibody and molecules comprising the antibody
JP2021531005A5 (https=)
JP2021524249A5 (https=)
RU2017145150A (ru) Антитело против pdl-1, его фармацевтическая композиция и применение
JP2017149720A5 (https=)
JPWO2022170971A5 (https=)
JPWO2020244528A5 (https=)
JP2020501598A5 (https=)
JP2026041845A5 (https=)
JP2021533796A5 (https=)
JPWO2019170898A5 (https=)
JPWO2023143263A5 (https=)
EP3962525A1 (en) Combination of her2 antibodies
CN114616245B (zh) 一种抗cd38的抗体及其用途
JPWO2023186092A5 (https=)
JPWO2019170885A5 (https=)
CN116847883A (zh) 抗cd73抗体和抗entpd2抗体的剂量方案及其用途
JPWO2023186077A5 (https=)
CN115551888B (zh) 抗cd73抗体及其用途
JPWO2023186078A5 (https=)
JPWO2019166596A5 (https=)
JPWO2022188652A5 (https=)
RU2025116107A (ru) Антитело и его применение
JPWO2023143227A5 (https=)